FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285087208> ?p ?o ?g. }

• W4285087208 endingPage "e38366" @default.
• W4285087208 startingPage "e38366" @default.
• W4285087208 abstract "Background The modern management of chronic pain is largely focused on improving functional capacity (often despite ongoing pain) by using graded activation and exposure paradigms. However, many people with chronic pain find functional activation programs aversive, and dropout rates are high. Modern technologies such as virtual reality (VR) could provide a more enjoyable and less threatening way for people with chronic pain to engage in physical activity. Although VR has been successfully used for pain relief in acute and chronic pain settings, as well as to facilitate rehabilitation in conditions such as stroke and cerebral palsy, it is not known whether VR can also be used to improve functional outcomes in people with chronic pain. Objective This study aimed to assess the feasibility of conducting an adequately powered randomized controlled trial (RCT) to test the efficacy of VR in a chronic pain treatment center and assess the acceptability of an active VR treatment program for patients in this setting. Methods For this mixed methods pilot study, which was designed to test the feasibility and acceptability of the proposed study methods, 29 people seeking treatment for chronic pain were randomized to an active VR intervention or physiotherapy treatment as usual (TAU). The TAU group completed a 6-week waitlist before receiving standard treatment to act as a no-treatment control group. The VR intervention comprised twice-weekly immersive and embodied VR sessions using commercially available gaming software, which was selected to encourage movement. A total of 7 VR participants completed semistructured interviews to assess their perception of the intervention. Results Of the 99 patients referred to physiotherapy, 53 (54%) were eligible, 29 (29%) enrolled, and 17 (17%) completed the trial, indicating that running an adequately powered RCT in this setting would not be feasible. Despite this, those in the VR group showed greater improvements in activity levels, pain intensity, and pain interference and reported greater treatment satisfaction and perceived improvement than both the waitlist and TAU groups. Relative effect sizes were larger when VR was compared with the waitlist (range small to very large) and smaller when VR was compared with TAU (range none to medium). The qualitative analysis produced the following three themes: VR is an enjoyable alternative to traditional physiotherapy, VR has functional and psychological benefits despite continued pain, and a well-designed VR setup is important. Conclusions The active VR intervention in this study was highly acceptable to participants, produced favorable effects when compared with the waitlist, and showed similar outcomes as those of TAU. These findings suggest that a confirmatory RCT is warranted; however, substantial barriers to recruitment indicate that incentivizing participation and using a different treatment setting or running a multicenter trial are needed." @default.
• W4285087208 created "2022-07-14" @default.
• W4285087208 creator A5002531372 @default.
• W4285087208 creator A5006561757 @default.
• W4285087208 creator A5017429629 @default.
• W4285087208 creator A5048208200 @default.
• W4285087208 creator A5050161632 @default.
• W4285087208 creator A5063180656 @default.
• W4285087208 creator A5069718504 @default.
• W4285087208 creator A5081786987 @default.
• W4285087208 date "2022-07-13" @default.
• W4285087208 modified "2023-10-04" @default.
• W4285087208 title "Active Virtual Reality for Chronic Primary Pain: Mixed Methods Randomized Pilot Study" @default.
• W4285087208 cites W1493554727 @default.
• W4285087208 cites W1504926627 @default.
• W4285087208 cites W1539080487 @default.
• W4285087208 cites W1556027972 @default.
• W4285087208 cites W1936508772 @default.
• W4285087208 cites W1964406984 @default.
• W4285087208 cites W1981286526 @default.
• W4285087208 cites W2011423258 @default.
• W4285087208 cites W2011899692 @default.
• W4285087208 cites W2027720123 @default.
• W4285087208 cites W2029662381 @default.
• W4285087208 cites W2080902960 @default.
• W4285087208 cites W2096218277 @default.
• W4285087208 cites W2098082628 @default.
• W4285087208 cites W2102230060 @default.
• W4285087208 cites W2110112325 @default.
• W4285087208 cites W2121860971 @default.
• W4285087208 cites W2124567921 @default.
• W4285087208 cites W2135412825 @default.
• W4285087208 cites W2139290189 @default.
• W4285087208 cites W2144440938 @default.
• W4285087208 cites W2320909684 @default.
• W4285087208 cites W2332019618 @default.
• W4285087208 cites W2344008107 @default.
• W4285087208 cites W2345617275 @default.
• W4285087208 cites W2404431760 @default.
• W4285087208 cites W2461885327 @default.
• W4285087208 cites W2506161560 @default.
• W4285087208 cites W2519465129 @default.
• W4285087208 cites W2561558426 @default.
• W4285087208 cites W2567713982 @default.
• W4285087208 cites W2588906980 @default.
• W4285087208 cites W2593921287 @default.
• W4285087208 cites W2597764693 @default.
• W4285087208 cites W2612815242 @default.
• W4285087208 cites W2752018620 @default.
• W4285087208 cites W2782641492 @default.
• W4285087208 cites W2802051196 @default.
• W4285087208 cites W2883630754 @default.
• W4285087208 cites W2883658446 @default.
• W4285087208 cites W2900817205 @default.
• W4285087208 cites W2903549197 @default.
• W4285087208 cites W2955599831 @default.
• W4285087208 cites W2976186436 @default.
• W4285087208 cites W2978139211 @default.
• W4285087208 cites W2991386074 @default.
• W4285087208 cites W3017878292 @default.
• W4285087208 cites W3049246838 @default.
• W4285087208 cites W3082091395 @default.
• W4285087208 cites W3086208718 @default.
• W4285087208 cites W3127104877 @default.
• W4285087208 cites W3165802878 @default.
• W4285087208 cites W3165837403 @default.
• W4285087208 cites W3169167385 @default.
• W4285087208 cites W3194956376 @default.
• W4285087208 cites W4254315309 @default.
• W4285087208 cites W4295135118 @default.
• W4285087208 cites W4299663771 @default.
• W4285087208 doi "https://doi.org/10.2196/38366" @default.
• W4285087208 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35830224" @default.
• W4285087208 hasPublicationYear "2022" @default.
• W4285087208 type Work @default.
• W4285087208 citedByCount "5" @default.
• W4285087208 countsByYear W42850872082023 @default.
• W4285087208 crossrefType "journal-article" @default.
• W4285087208 hasAuthorship W4285087208A5002531372 @default.
• W4285087208 hasAuthorship W4285087208A5006561757 @default.
• W4285087208 hasAuthorship W4285087208A5017429629 @default.
• W4285087208 hasAuthorship W4285087208A5048208200 @default.
• W4285087208 hasAuthorship W4285087208A5050161632 @default.
• W4285087208 hasAuthorship W4285087208A5063180656 @default.
• W4285087208 hasAuthorship W4285087208A5069718504 @default.
• W4285087208 hasAuthorship W4285087208A5081786987 @default.
• W4285087208 hasBestOaLocation W42850872081 @default.
• W4285087208 hasConcept C118552586 @default.
• W4285087208 hasConcept C141071460 @default.
• W4285087208 hasConcept C154945302 @default.
• W4285087208 hasConcept C159110408 @default.
• W4285087208 hasConcept C168563851 @default.
• W4285087208 hasConcept C1862650 @default.
• W4285087208 hasConcept C194969405 @default.
• W4285087208 hasConcept C2778818304 @default.
• W4285087208 hasConcept C2780665704 @default.
• W4285087208 hasConcept C2781118164 @default.
• W4285087208 hasConcept C2910959060 @default.

• next